Pharma Redx is latest firm to delist from AIM
Redx chair Dr Jane Griffiths said: “We believe our current market valuation is not reflective of our track record or future potential”
Evening Standard ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from Redx
Drug developer Redx Pharma's $425m merger with Jounce Therapeutics off after takeover agreed
Jounce is to be takeover by Concentra Biosciences in which Tang Capital Partners is the controlling shareholder
Birmingham Post ·
Planned $425m merger under threat after rival's 'unsolicited' takeover bid
The merger was originally expected to be completed in the coming months
Birmingham Post ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Birmingham Post
Evening Standard
Organisations
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Topics
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
